Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.